Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 3c, Revenues Beat; Maintains FY20 EPS/Revenue Guidance
Go back to Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 3c, Revenues Beat; Maintains FY20 EPS/Revenue Guidance| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 18.15 +0.88 (5.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.27 | 52 Week High | $0.19 | |||
| Open | $17.07 | 52 Week Low | $0.07 | |||
| Day High | $18.17 | P/E | N/A | |||
| Day Low | $16.87 | EPS | $-0.01 | |||
| Volume | 2,006,514 | |||||
